Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

No reported Retained Earnings figures are available to summarize.

Retained Earnings history

Currency unavailable · from the balance sheet

No Retained Earnings data reported for this period type.

Retained Earnings vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Retained Earnings for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RNAAtrium Therapeutics, Inc.Mar 2026$12.13M USD——4.1%
IKTInhibikase Therapeutics, Inc.Mar 2026-$159.06M USD-47.1%—91.8%
TNYATenaya Therapeutics, Inc.Mar 2026-$624.28M USD-15.3%—462.2%
NAMSNewAmsterdam Pharma Company N.V.Jun 2026-$874.97M USD-42.2%—124.2%
CYTKCytokinetics, IncorporatedJun 2026-$3.89B USD-29.8%—202.2%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-36.0%—124.2%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.